Physician profile
Justin Abraham
NPI 1386318137
$1,526.98
in general payments reported to CMS, 2019-2025
14 companies · $477 in 2025
The $477 reported for 2025 was more than what 76% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $218 · 2022: $598 · 2023: $91.97 · 2024: $143 · 2025: $477.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $711.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $711.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $262.90 | 2022-2025 | Precision 1, Precision7, Total30 |
| Coopervision INC. | $185.18 | 2024-2025 | Clariti Contact Lens, Myday Contact Lens |
| Bausch & Lomb Americas INC. | $162.47 | 2022-2025 | Vyzulta, Xiidra, Miebo |
| Aerie Pharmaceuticals, INC. | $161.15 | 2021 | |
| Optos, INC. | $159.41 | 2025 | |
| Abbvie INC. | $152.65 | 2022 | |
| Novartis Pharmaceuticals Corporation | $144.58 | 2022 | |
| Allergan, INC. | $109.65 | 2022 | |
| Thea Pharma INC. | $47.48 | 2023 | Iyuzeh |
| Johnson & Johnson Vision Care, INC. | $41.79 | 2025 | |
| Glaukos Corporation | $38.79 | 2021 | |
| Amgen INC. | $23.90 | 2024 | Uplizna |
| Biotissue Holdings INC. | $19.44 | 2022 | |
| Eyevance Pharmaceuticals LLC | $17.59 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Justin Abraham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.